Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of High-Dose Rifampin in Patients With New, Smear-Positive TB

NCT01408914 is registered in ClinicalTrials.gov with Harvard University Faculty of Medicine as lead sponsor.

NCT NCT01408914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01408914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of High-Dose Rifampin in Patients With New, Smear-Positive TB
Lead sponsor
Harvard University Faculty of Medicine
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2013
Completion date
April 30, 2016
Enrollment
180 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis